There is a particular kind of tension that builds when a company’s most promising asset is also its biggest liability. Rocket Lab is living that tension right now. The stock has spent the summer whipsawing between euphoria and despair, and the next few weeks will determine which emotion wins out.
The immediate catalyst for the latest bounce was tangible enough. Rocket Lab secured three additional Electron launches for Japanese satellite operator iQPS, with missions slated to begin in late 2027. That brings the total contracted iQPS missions to 18, deepening a partnership that has been running since 2023, when Rocket Lab first became the company’s primary launch provider. Seven QPS-SAR satellites have already made it to orbit aboard Electron rockets. Repeat customers, in this business, are the strongest vote of confidence available.
The market responded with an 8.69 percent jump on Monday, a sharp rebound after a brutal stretch that wiped out roughly a quarter of the stock’s value in a single month. That kind of snap-back can look like a dead-cat bounce, but the underlying picture suggests something more substantive. Rocket Lab is still up 58.81 percent year over year, and the recent sell-off looks less like a verdict on the business and more like a repricing of a known risk.
That known risk has a name: Neutron.
The Rocket That Keeps the Market Guessing
Rocket Lab’s medium-lift workhorse is scheduled for its maiden flight in the fourth quarter of 2026 — a timeline that has already slipped once. In January, during a hydrostatic pressure test, the first stage burst. The company attributed the failure to a manufacturing defect, but the incident rattled confidence and underscored how much capital is riding on flawless execution.
There is, at least, a counterweight to that setback. The full-duration burn test of the Archimedes engine has been completed successfully, a milestone that validates the company’s in-house propulsion technology. The rest of the vehicle is still working through its qualification phase, and the market is now trying to price the probability that no further structural failures emerge before the Q4 target.
That calculation has produced a stock that is, by any measure, deeply conflicted. On a twelve-month basis, shares have gained 63.99 percent. But they sit 52.69 percent below their annual high of 133.80 euros, and the recent trading session saw a 3.26 percent advance to 63.30 euros — still well beneath the 50-day moving average of 80.97 euros. The weekly gain of 12.83 percent offers some comfort, but the technical picture remains fragile.
The Bull Case: A Contract Machine That Keeps Humming
What the pessimists tend to overlook is that Rocket Lab’s commercial engine has not stalled while Neutron works through its teething problems. The Electron rocket has been enjoying a record phase since the start of 2026, with launch orders and revenues climbing steadily. Government and defense work has emerged as an increasingly reliable pillar: the company recently won a 266 million dollar contract from the US Space Force for twelve suborbital launches, with options for six additional HASTE missions. It has also agreed to build geostationary satellites for the Space Force on its Lightning platform.
Should investors sell immediately? Or is it worth buying Rocket Lab?
These are not speculative orders. Defense contracts carry lower execution risk than commercial constellations, and their recurring nature builds a revenue floor that holds even if Neutron’s schedule slips further. The analyst consensus sees a price target of 99.37 euros, implying roughly 57 percent upside from current levels. That optimism rests on the assumption that a successful Neutron debut would accelerate commercial demand and attract high-margin constellation contracts.
The Bear Case: Cash Burn and Calendar Risk
The counterargument is equally straightforward and harder to dismiss. Developing a medium-lift rocket consumes capital at a ferocious pace, and the January tank failure made that reality more acute. Rocket Lab remains unprofitable and continues to burn through cash. Every additional delay to Neutron’s first flight stretches the balance sheet further and raises the specter of dilution.
The stock’s volatility profile tells its own story: annualized 30-day volatility sits at 100.12 percent. This is a stock that can lose a quarter of its value in a month — it just did — and the July sell-off appears to have priced in exactly the Neutron risk that bears have been hammering on. What got lost in that rout, however, was that Electron and the defense business were growing independently of Neutron’s fate.
The Numbers That Will Settle It
The next real test arrives with the second-quarter earnings report, due Monday, August 10, 2026. The precedent from the prior quarter is encouraging: after Q1 results, the stock jumped 34 percent, powered by revenue of 200.3 million dollars — a 63.5 percent increase year over year. If that pattern of strong Electron and Space Systems growth repeats, Monday’s rebound could prove to be the start of a genuine recovery rather than a fleeting flicker.
The moving averages offer a rough guide to what a stabilization might look like. The stock sits just 9.05 percent below its 200-day average, while the gap to the 50-day average is a much wider 25.40 percent. That configuration suggests the stock is drifting back toward its longer-term trend rather than breaking it. A return toward the 100-day average of 78.27 euros would signal that investor confidence is rebuilding.
The downside scenario is equally well-defined. New technical problems during Neutron’s final integration, or unexpected cost overruns on the Iridium Communications acquisition — expected to close by mid-2027 — could send shares back toward the annual low of 32.60 euros.
For now, Rocket Lab is a study in dualities: a record order book against a halved share price, a tested engine against a burst tank, a stock that has lost a quarter of its value in a month yet remains up nearly 59 percent on the year. The August earnings report will reveal which of those forces wins the argument.
Ad
Rocket Lab Stock: Buy or Sell?! New Rocket Lab Analysis from August 4 delivers the answer:
The latest Rocket Lab figures speak for themselves: Urgent action needed for Rocket Lab investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 4.
Rocket Lab: Buy or sell? Read more here...
